Asuragen Nets $3.8M in SBIR/STTR Grants | GenomeWeb

NEW YORK (GenomeWeb News) – Asuragen has won $3.8 million in new stimulus funding from the National Institutes of Health, which it will use to advance its molecular diagnostics programs for cancer and genetic diseases, the company said today.

The company said that it received the funding through the Small Business Innovation Research and Small Business Technology Transfer programs, and the American Recovery and Reinvestment Act.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: ancient Ethiopian genome indicates greater Eurasian backflow into Africa, sequencing to diagnose cutaneous T cell lymphoma, and more.

The US House of Representatives science committee has passed a bill to require NSF to ensure it only funds projects that are in the national interest.

DuPont teams with genome editing firm Caribou Biosciences for agricultural applications of the technology.

A blogger reviews her experience learning about her gut microbiome by shipping a sample to uBiome.